ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Disease Activity"

  • Abstract Number: 0186 • ACR Convergence 2020

    The Number of Associated Comorbidities Can Impact Disease Activity Scores Independently from Objective Measures of Inflammation in Patients with Rheumatoid Arthritis

    Magali Zanotti-Cavazzoni1 and Gabriela Avila2, 1Sociedad Paraguaya de Reumatología, Asunción, Paraguay, 2Sociedad Paraguaya de Reumatologia, Asuncion, Paraguay

    Background/Purpose: Disease activity scores (DAS) are used as tools to assess persistent inflammation and need for therapeutic escalation in patients with Rheumatoid arthritis (RA). One…
  • Abstract Number: 0315 • ACR Convergence 2020

    The Role of Ultrasound for the Assessment of Psoriatic Arthritis Patients with Fibromyalgia

    Ari Polachek1, Victoria Furer2, Mirna Zureik3, Sharon Nevo3, Liran Mendel4, David Levartovsky2, Jonathan Wollman3, Valerie Aloush2, Mark Berman2, Ilana Kaufman5, Reut Tzemach4, Marina Anouk6, Ofir Elalouf7, Hagit Padova4, Or Carmi8, Tali Eviatar9, Yael Lahat goldstein2, Hagit Sarbagil-Maman10, Sara Borok Lev-Ran2, Adi Broide3, Lihi Eder11, Daphna Paran2 and Ori Elkayam3, 1Tel Aviv Sourasky Medical Center, Petah-Tikva, Israel, 2Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, 4Souraaky Medical Center, Tel-Aviv, Israel, 5Tel Aviv Sourasky Medical Center, Petah-Tiqwa, Israel, 6Souraaky Medical Center, Tel Aviv, Israel, 7Souraaky Medical Center, Herzliya, Israel, 8Souraaky Medical Center, herzelia, Israel, 9Tel Aviv Sourasky Medical Center, Givataim, Israel, 10Tel-Aviv Sourasky Medical Center, Kiryat Ono, Israel, 11University of Toronto, Toronto, ON, Canada

    Background/Purpose: The presence of fibromyalgia (FMS) in psoriatic arthritis (PsA) patients increases the scores of the clinical measures of disease activity. The aim of this…
  • Abstract Number: 0721 • ACR Convergence 2020

    Validation of New Antirheumatic Drug Use as a Proxy for Increased JIA Disease Activity

    Avinash Gabbeta1, Evan Mulvihill2, Timothy Beukelman3, James Lewis4, Carlos Rose5, Brian Strom6 and Daniel Horton7, 1St. Christopher's Hospital for Children, Philadelphia, PA, 2Nemours A.I. duPont Hospital for Children, Wilmington, DE, 3University of Alabama at Birmingham, Birmingham, AL, 4University of Pennsylvania, Philadelphia, PA, 5Nemours A.I. duPont Hospital for Children, Wilmingon, DE, 6Rutgers University, Newark, NJ, 7Rutgers University, New Brunswick, NJ

    Background/Purpose: Administrative claims databases are valuable tools for studying treatment effects in large JIA populations but do not contain direct measures of disease activity, limiting…
  • Abstract Number: 0829 • ACR Convergence 2020

    International Comparison of Japanese and US Cross Country Utilization of RA Medications

    Hisashi Yamanaka1, Mitsumasa Kishimoto2, Kazuhisa Nakano3, Kenta Misaki4, Yuji Yamanishi5, Hiroaki Dobashi6, Masamitsu Natsumeda7, Toshiaki Miyamoto8, Koichi Amano9, Akira Sagawa10, Norihiko Koido11, Corrona Japan Consortium12, Leslie Harrold13, Tin-chi Lin13, Jeffrey Greenberg14 and Yoshiya Tanaka3, 1Sanno Medical Center, Tokyo, Japan, Tokyo, Japan, 2Department Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan, 3The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 4Kitaharima Medical Center, Ono, Japan, 5Hiroshima Rheumatology Clinic, Hiroshima, Japan, 6Department of Internal Medicine, Division of Haematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan, 7Mabi Memorial Hospital, Kurashiki, Japan, 8Seirei Hamamatsu General Hospital, Hamamatsu, Japan, 9Saitama Medical Center, Kawagoe, Japan, 10Sagawa Akira Rheumatology Clinic, Sapporo, Japan, 11Kawasaki RA & IM Clinic, Kawasaki, Japan, 12Corrona Japan Consortium, Japan, Japan, 13Corrona, LLC, Waltham, MA, 14Corrona, LLC and NYU School of Medicine, Waltham, MA

    Background/Purpose: Little is known regarding differences in DMARD utilization across countries. A better understanding is needed to contextualize findings from different countries.1 Using the same…
  • Abstract Number: 0989 • ACR Convergence 2020

    Withdrawal of MMF Is Safe in Quiescent Renal and Non-Renal SLE: Results from a Multi-Center Randomized Trial

    Eliza Chakravarty1, Tammy Utset2, Diane Kamen3, Gabriel Contreras4, W. Joseph McCune5, Kenneth Kalunian6, Cynthia Aranow7, Megan Clowse8, Elena Massarotti9, Ellen Goldmuntz10, Jessica Springer10, Lynette Keyes-Elstein11, Bill Barry11, Ashley Pinckney11 and Judith James12, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Chicago, Chicago, IN, 3Medical University of South Carolina, Charleston, SC, 4University of Miami Miller School of Medicine, Miami, 5University of Michigan, Ann Arbor, MI, 6University of California San Diego, La Jolla, CA, 7Feinstein Institutes for Medical Research, Manhasset, NY, 8Duke University, Chapel Hill, NC, 9Brigham and Women's hospital, Boston, MA, 10NIH/NIAID, Rockville, MD, 11Rho, Durham, NC, 12Oklahoma Medical Research Foundation, Oklahoma City

    Background/Purpose: Mycophenolate Mofetil (MMF) is standard of care therapy for long term treatment of lupus nephritis and other manifestations of SLE.  However, it is associated…
  • Abstract Number: 1232 • ACR Convergence 2020

    Association of Low Hemoglobin with Efficacy and Patient-reported Outcomes in Three Phase III Studies of Sarilumab (TARGET, MOBILITY and MONARCH)

    Andrea Rubbert Roth1, Daniel Furst*2, Stefano Fiore3, Amy Praestgaard4, Vivian Bykerk5, Clifton Bingham III6 and Christina Charles-Schoeman7, 1Klinik für Rheumatologie, Kantonsspital St Gallen, St Gallen, Sankt Gallen, Switzerland, 2Department of Medicine, Division of Rheumatology, University of California at Los Angeles, Los Angeles, California, USA, Los Angeles, CA, 3Sanofi, Bridgewater, NJ, 4Sanofi, Cambridge, MA, 5Hospital for Special Surgery, New York, NY, 6Johns Hopkins University, Baltimore, MD, 7University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Anemia is a common comorbidity in patients (pts) with RA, and changes in hemoglobin (Hb) levels are associated with changes in inflammatory disease activity. Since…
  • Abstract Number: 1393 • ACR Convergence 2020

    Systemic Sclerosis: Subclinical Aterosclerosis and Morbimortality

    Miriam Retuerto1, Jose Luis Rosales2, Maria Martin1, Beatriz Joven1 and Patricia E Carreira1, 1Hospital universitario 12 de octubre, Madrid, Spain, 2Hospiten Rambla, Santa Cruz de Tenerife, Spain

    Background/Purpose: Rheumatic diseases are associated with accelerated atherosclerosis, and an increase in cardiovascular morbidity and mortality. This process is mediated by classic cardiovascular risk factors…
  • Abstract Number: 1724 • ACR Convergence 2020

    A Feasible and Efficient Approach to Implementing Rheumatoid Arthritis Disease Activity Measure in a Busy Rheumatology Clinic: A Quality Improvement Project

    Ali H.Ali1, Amani Elghafri2, Mosaab Mohameden3, Mandeep Sidhu2 and Candice Reyes Yuvienco4, 1University of California San Francisco Fresno, Fresno, CA, 2University of California San Francisco Fresno, Fresno, 3University of Cincinnati, Cincinnati, OH, 4University of California San Francisco Fresno, Clovis, CA

    Background/Purpose: The treatment of Rheumatoid Arthritis (RA) has witnessed a substantial change over last the 20 years, with disease remission becoming an achievable goal. Treat-to-target…
  • Abstract Number: 1818 • ACR Convergence 2020

    IgG and IgA Autoantibodies Against L1 ORF1p Expressed in Granulocytes Correlate with Granulocyte Consumption and Disease Activity in Pediatric Systemic Lupus Erythematosus

    Kennedy Ukadike1, Kathryn Ni1, Victoria Carter1, Martin Taylor2, John LaCava3, Lauren Pachman4, Xiaoxing Wang1, Mary Eckert5, Anne Stevens1, Christian Lood1 and Tomas Mustelin1, 1University of Washington, Seattle, WA, 2Massachusetts General Hospital, Boston, MA, 3Rockefeller University, New York, NY, 4Department of Pediatrics, Northwestern University Feinberg School of Medicine; The Ann and Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Rheumatology; The CureJM Center of Excellence in Juvenile Myositis Research and Care, The Stanley Manne Children's Research Center of Chicago, Lake Forest, IL, 5Seattle Children's Hospital, Seattle, WA

    Background/Purpose: To quantitate autoantibodies against the RNA-binding p40 (ORF1p) protein encoded by the L1 retroelement, expression of p40 itself, and markers of neutrophil death in…
  • Abstract Number: 2031 • ACR Convergence 2020

    Which Disease Activity Outcome Measure Discriminates Best in Axial Spondyloarthritis? A Systematic Literature Review and Meta-analysis

    Augusta Ortolan1, Victoria Navarro-Compán2, Alexandre Sepriano3, Robert Landewé4, Désirée van der Heijde5 and Sofia Ramiro6, 1Leiden University Medical Center, Padova, Italy, 2Hospital Universitario La Paz IdiPaz, Madrid, Pais Vasco, Spain, 3Leiden University Medical Center, Portela Loures, Portugal, 4Amsterdam University Medical Center & Zuyderland Hospital, Amsterdam, Netherlands, 5Leiden University Medical Center, Leiden, Netherlands, 6Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: Several disease activity response and status criteria are used to assess treatment efficacy in RCTs in axial spondyloarthritis (axSpA). Response criteria include: the Assessment…
  • Abstract Number: 0198 • ACR Convergence 2020

    A Prospective Cohort Study of Vehicle Control as a Measure of Driving Performance in Patients with Rheumatoid Arthritis

    Kaleb Michaud1, Jennifer Merickel1, Yeongjin Gwon1, Harlan Sayles1, Haley Kampschnieder1, Rebecca Hiebert1, Alison Petro1, Bryant England1, Matthew Rizzo1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Automobile driving is an instrumental activity of daily living. Owing to symptoms and functional impairment, patients with rheumatoid arthritis (RA) rely disproportionately on driving…
  • Abstract Number: 0320 • ACR Convergence 2020

    Assessment of Implementation of Treat to Target Concept Using Validated Composite Scores in Psoriatic Arthritis Patients

    Tal Gazitt1, Muhanad Abu Elhija1, Amir Haddad1, Idit Lavi1, Muna Elias1 and Devy Zisman1, 1Carmel Hospital, Haifa, Israel

    Background/Purpose: To assess the implementation of the “Treat-to-Target” (T2T) concept using validated composite disease activity scores in daily management of psoriatic arthritis (PsA).Methods: A retrospective…
  • Abstract Number: 0725 • ACR Convergence 2020

    A Data Science Evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Questionnaire for Improving Management of JIA Patients

    Humbert Quesada-Masachs1, Michalis Faloutsos2, Shomit Ghose3, Sara Marsal4, Consuelo Modesto4 and Estefania Quesada-Masachs5, 1University of California Riverside, San Diego, 2University of California Riverside, Riverside, 3University of California Berkeley, San Francisco, 4Hospital Universitari Vall d'Hebron, Barcelona, Spain, 5Hospital Universitari Vall d'Hebron, San Diego

    Background/Purpose: The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a questionnaire developed to comprehensively assess Juvenile Idiopathic Arthritis (JIA) patients. Despite being translated into 54…
  • Abstract Number: 0831 • ACR Convergence 2020

    Sociodemographic, Disease, and Medication Profile of RA Patients Under 65 Years Compared with 65 Years or Older at Registry Enrollment: Real World Results from a Rheumatoid Arthritis Cohort

    Mohammad Movahedi1, Angela Cesta2, Xiuying Li3 and Claire Bombardier4, 1Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 2Toronto General Hospital Research Institute, Toronto, ON, Canada, 3Toronto General Hospital Research Institute, Toronto, Canada, 4Institute for Work and Health, Toronto, ON, Canada

    Background/Purpose: Age is an important factor that can affect disease course, physical function and treat to target strategy for patients with rheumatoid arthritis (RA). We…
  • Abstract Number: 1018 • ACR Convergence 2020

    Seasonal Variation in the Treat-to-Target Rate of Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE): A Cohort Study on Self-reported Data from Smart System of Disease Management (SSDM)

    Lijun Wu1, Zhanyun Da2, Hongzhi Wang3, Jianlin Huang4, Bin Wu5, Henglian Wu6, Fang He7, Fen Wang8, Rong Du9, Linchong Su10, Qiaoqiao Yao11, Rui Wu12, Zhenbin Li13, Xiaohan Wang14, Yuhong Liu9, Chuanjing Li15, Xiaomei Lei16, Minjun Wang17, Hui Xiao17, Yuhua Jia18, Yihong Liu17, Xin Chen17, Shengsong Jia17, Bing Wu18, Yuan Liu17, Fei Xiao18 and Lingli Dong19, 1People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (People's Republic), 2The affiliated Hospital of Nantong University, Nantong, Jiangsu, China (People's Republic), 3The First Hospital of Jiaxing, Jiaxing, China (People's Republic), 4The sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China (People's Republic), 5Chongqing Hospital of Traditional Chinese Medicine, chongqing, Chongqing, China (People's Republic), 6Dongguan Donghua Hospital, Dongguan, Guangdong, China (People's Republic), 7Suining Central Hospital, Suining, Sichuan, China (People's Republic), 8The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China (People's Republic), 9Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China (People's Republic), 10Minda Hospital of Hubei Minzu University, Enshi, Hubei, China (People's Republic), 11China Resources Wuhan Iron and Steel General Hospital, Wuhan, Hubei, China (People's Republic), 12The First Affiliated Hospital of Nanchang University, Nanchang, China (People's Republic), 13Chinese people ’s liberation army joint service support force 980 hospital, shijiazhuang, Jiangxi, China (People's Republic), 14Anyang district hospital, Anyang, Henan, China (People's Republic), 15Xiaogan Central Hospital of Hubei Province, Xiaogan, Hubei, China (People's Republic), 16Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China (People's Republic), 17Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 18Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China (People's Republic), 19Tongji Hospital Affiliated to Tongji Medical College of HUST, Wuhan, Hubei, China (People's Republic)

    Background/Purpose: Treat-to-Target(T2T) is the main therapeutic strategy for patients with RA and SLE. There has been no report on comparation of seasonal variations on T2T…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 65
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.